SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $388,000 | +84.8% | 42,419 | +12.7% | 0.00% | – |
Q4 2018 | $210,000 | -76.6% | 37,651 | -50.0% | 0.00% | -100.0% |
Q3 2018 | $896,000 | +131.5% | 75,302 | +98.8% | 0.00% | – |
Q2 2018 | $387,000 | +31.2% | 37,880 | +66.7% | 0.00% | – |
Q1 2018 | $295,000 | +33.5% | 22,718 | 0.0% | 0.00% | – |
Q4 2017 | $221,000 | -33.8% | 22,718 | 0.0% | 0.00% | – |
Q3 2017 | $334,000 | -8.7% | 22,718 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $366,000 | +363.3% | 22,718 | +360.5% | 0.00% | – |
Q1 2017 | $79,000 | +31.7% | 4,933 | 0.0% | 0.00% | – |
Q4 2016 | $60,000 | -11.8% | 4,933 | 0.0% | 0.00% | – |
Q3 2016 | $68,000 | – | 4,933 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
IFP Advisors, Inc | 50 | $1,000 | 0.00% |
Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |